查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999034

骨质密度检测设备市场：中心型双能量X光吸收法（DXA）、定量超音波、週边型DXA，依最终用户划分－2026-2032年全球市场预测

Bone Densitometer Market by Central DXA, Quantitative Ultrasound, Peripheral DXA, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，骨质密度检测设备市场价值将达到 3.5514 亿美元，到 2026 年将成长至 3.7687 亿美元，到 2032 年将达到 5.0716 亿美元，复合年增长率为 5.22%。

主要市场统计数据
基准年 2025 3.5514亿美元
预计年份：2026年 3.7687亿美元
预测年份 2032 5.0716亿美元
复合年增长率 (%) 5.22%

随着临床需求、影像技术创新和医疗保健服务重点的交汇，骨骼密度测量技术的角色和采购方式正在被重新定义。

骨骼密度测量处于人口结构变化、临床需求和影像技术创新三者交汇的阶段，迫使临床医生、管理者和医疗设备製造商重新评估其工作重点。随着人口老化和人们对骨骼健康意识的提高，曾经作为辅助手段的诊断过程如今在预防医学和慢性病管理中发挥着核心作用。同时，技术进步正在改变集中式影像设施和分散式筛检方法之间的平衡，为骨骼健康评估的地点、方式和评估人员创造了新的选择。

技术小型化、先进分析和护理模式的整合正在改变临床路径、筹资策略和供应商差异化。

在骨骼密度测量领域，硬体、分析技术和诊疗模式的创新正在带来革命性的变革，这些变革共同重塑临床实践和市场奖励。更小巧、更便携的设备正在拓展诊断应用范围，使其不再局限于三级医疗机构，从而能够在门诊中心和社区诊所进行即时筛检（POC）。影像处理和人工智慧（AI）技术的同步发展，为自动化品管和高级骨折风险评估提供了支持，从而提高了诊断的可靠性并降低了检查者之间的差异。

贸易政策的变化和关税压力正在促使医疗影像设备整个价值链进行供应链重组、进口总成本重新评估和筹资策略调整。

近期关税调整和贸易政策变化给依赖跨境供应链供应医疗影像设备及其组件的供应商、经销商和医疗服务提供者带来了新的挑战。关税措施正在影响供应商的零件采购决策，许多製造商正在重新评估其全球製造地，以降低额外的进口成本并减少政策变化的风险。为此，一些製造商正在将零件采购转移到其他地区，或加快本地组装，以避免额外关税并缩短前置作业时间。

诊断中心和医院中特定模式部署对临床工作流程、采购政策和设备设计要求的影响。

细分市场分析揭示了不同模式和医疗机构之间的交集，从而影响临床效用、购买理由和采用模式。基于中心式双能量X光吸收法（DXA），市场结构以诊断中心和医院为中心。诊断中心通常采用此系统来支援骨折风险评估和骨质疏鬆症评估服务，优先考虑处理能力和门诊追踪；而医院则利用中心式DXA开展综合骨折联络项目，强调全面的护理协调，并用于住院和门诊骨质疏鬆症管理。基于定量超音波（QUS），该技术常被诊断中心采用，用于在社区筛检活动中优先考虑快速骨折风险筛检和骨质疏鬆症评估；也被医院采用，在放射科资源有限的情况下，用于分流、手术全期评估和床边评估，作为中心式DXA的补充。这种基于外周 DXA 的模式通常部署在诊断中心，为社区推广和与基层医疗合作提供移动、低成本的骨折风险和骨质疏鬆症评估方案；或者部署在医院，因为医院无法获得中央 DXA，外周设备可以支持重点评估、目标患者群体的监测和术前评估。

区域监管差异、人口趋势和医疗保健服务模式正在全球市场中形成不同的需求模式和区域性商业化策略。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的临床重点、监管预期和商业策略的影响各不相同。在美洲，人口老化和广泛的基层医疗网络推动了对便利诊断途径和综合骨折预防计画的需求，医疗系统正在投资集中式和分散式骨骼密度解决方案，以支持长期管理和结果追踪。同时，欧洲、中东和非洲地区呈现高度异质性，各国在法律规范、报销模式和医疗基础设施方面存在显着差异。因此，供应商越来越倾向于寻求特定区域的监管批准和灵活的商业模式，以适应公共采购週期和国家筛检政策。

竞争优势源自于检验的影像诊断效能​​、整合的分析能力、强大的服务模式以及以合作伙伴主导的打入市场策略。

竞争格局的核心在于仪器性能、软体分析、服务交付和商业性柔软性之间的相互作用。领先的供应商透过经过检验的测量精度、低剂量成像以及与电子健康记录和临床决策支援系统的互通性来脱颖而出，而专注于特定领域的厂商则强调便携性、经济性和针对性应用，例如外周筛检和社区骨折风险管理。服务模式也影响竞争格局。在资本预算受限且医疗系统要求营运成本可预测的环境下，提供维护、远距离诊断和分析即服务等打包服务的公司蓬勃发展。

供应商和服务提供者采取切实可行的步骤，以加强临床整合、建立供应链韧性并扩展服务主导经营模式，从而实现永续成长。

产业领导者应优先考虑能够提升临床相关性、业务永续营运和商业性灵活性的措施。首先，投资于互通性和临床整合，确保骨骼密度测量数据能够无缝流入电子健康记录和治疗路径。这将加速临床应用，并支援符合指南的决策。其次，实现供应链多元化，探索本地组装和双重采购模式，以降低贸易中断和关税波动带来的风险，从而提高交货可靠性并控製成本。第三，拓展服务范围，引入软体主导的分析、远端维护和订阅定价模式，将资本投资转化为预算有限的医疗系统中可控的营运成本。

我们采用高度透明的调查方法，结合专家访谈、监管趋势分析和产品对比评估，得出可操作的、检验的见解。

本研究整合了一手和第二手资料，旨在深入了解技术采纳、临床应用和商业性趋势。第一手资料包括对临床负责人、采购专家和行业高管的结构化访谈，以及产品规格、监管文件和说明设备性能和临床效用的同行评审文献。第二手资料包括公开的临床指南、医疗系统采购文件和製造商的技术白皮书，这些资料揭示了工作流程整合和服务模式。

透过整合临床趋势、技术要求和操作措施，并将它们结合起来，我们确定了一条实现更广泛应用和高价值骨骼健康评估的途径。

总之，在人口结构变化、技术创新和医疗服务体系变革的推动下，骨骼密度测量正从小众诊断工具发展成为预防性肌肉骨骼保健的核心要素。检测方法的特性与医疗环境的相互作用决定了设备的实施方式及其临床价值的实现。同时，贸易政策和供应链的考量增加了营运的复杂性，要求製造商和医疗系统都进行积极主动的管理。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章骨质密度检测设备市场（以中心DXA划分）

  • 诊断中心
    • 骨折风险评估
    • 骨质疏鬆症评估
  • 医院
    • 骨折风险评估
    • 骨质疏鬆症评估

第九章骨质密度检测设备市场—超音波

  • 诊断中心
    • 骨折风险评估
    • 骨质疏鬆症评估
  • 医院
    • 骨折风险评估
    • 骨质疏鬆症评估

第十章 週边双能量X射线吸收法骨质密度检测设备市场

  • 诊断中心
    • 骨折风险评估
    • 骨质疏鬆症评估
  • 医院
    • 骨折风险评估
    • 骨质疏鬆症评估

第十一章骨质密度检测设备市场：依最终用户划分

  • 医院
  • 诊断影像中心
  • 专科诊所
  • 研究机构

第十二章骨质密度检测设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章骨质密度检测设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章骨质密度检测设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国骨质密度检测设备市场

第十六章 中国骨质密度检测设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • CompuMed, Inc.
  • DMS Group, Inc.
  • GE HealthCare Technologies Inc.
  • Hitachi Aloka Medical, Ltd.
  • Hologic, Inc.
  • Medilink Co., Ltd.
  • Medonica Co., Ltd.
  • Mindways Software, Inc.
  • Norland Medical Systems, Inc.
  • OsteoSys Co., Ltd.
  • Scanflex Healthcare AB
  • Siemens Healthineers AG
  • Sunlight Medical Ltd.
Product Code: MRR-3D2FD205D8B8

The Bone Densitometer Market was valued at USD 355.14 million in 2025 and is projected to grow to USD 376.87 million in 2026, with a CAGR of 5.22%, reaching USD 507.16 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 355.14 million
Estimated Year [2026] USD 376.87 million
Forecast Year [2032] USD 507.16 million
CAGR (%) 5.22%

How converging clinical demand, imaging innovation, and care delivery priorities are redefining the role and procurement of bone densitometry technologies

Bone densitometry stands at the intersection of demographic pressure, clinical need, and imaging innovation, forcing clinicians, administrators, and device manufacturers to re-evaluate priorities. As populations age and awareness of bone health increases, diagnostic pathways that were once ancillary now occupy central roles in preventive care and chronic disease management. Concurrently, technological advances are altering the balance between centralized imaging suites and decentralized screening approaches, creating new choices around where, how, and by whom bone health is assessed.

Clinicians increasingly demand tools that integrate with electronic health records, provide reproducible longitudinal assessments, and support risk stratification that informs therapy decisions. Health systems, meanwhile, seek devices and service models that improve throughput, minimize radiation exposure, and offer favorable operating economics. Manufacturers respond with slimmer form factors, software-driven analytics, and enhanced workflow integration to address these converging pressures. Consequently, purchasing committees and clinical leaders must weigh diagnostic accuracy against operational flexibility and total cost of ownership.

Looking ahead, the convergence of imaging, data analytics, and point-of-care delivery will redefine the value proposition of bone densitometers. Strategic stakeholders who anticipate these shifts and prioritize interoperability, clinician usability, and patient-centered workflows will secure competitive advantage and drive more consistent, guideline-concordant care across settings.

Technological miniaturization, advanced analytics, and integrated care models converging to transform clinical pathways, procurement strategies, and vendor differentiation

The bone densitometry landscape is experiencing transformative shifts driven by innovation in hardware, analytics, and care models that together reshape clinical practice and market incentives. Device miniaturization and portability extend diagnostic reach beyond tertiary centers, enabling point-of-care screening in outpatient centers and community clinics. Parallel advances in image processing and artificial intelligence support automated quality control and enhanced fracture risk assessment, which improves diagnostic confidence and reduces inter-operator variability.

Moreover, shifting clinical pathways place a premium on longitudinal monitoring and interoperability with electronic health records and clinical decision support systems. As a result, software ecosystems that enable seamless data transfer and integrate bone health metrics into treatment algorithms gain strategic importance. Regulatory emphasis on safety and data integrity has tightened verification requirements, prompting vendors to accelerate validation efforts and manufacturers to provide robust post-market surveillance.

Financial and operational pressures also drive change. Health systems increasingly favor tools that reduce patient throughput times and administrative burden. Consequently, bundled service offerings, subscription-based models for software and analytics, and integrated service contracts become more prominent. Taken together, these shifts favor vendors and health providers that deliver end-to-end solutions that combine reliable hardware, validated analytics, and streamlined clinical workflows.

Trade policy shifts and tariff pressures prompting supply chain reconfiguration, landed cost reassessment, and procurement adaptation across imaging equipment value chains

Recent tariff adjustments and trade policy developments have created a new layer of complexity for suppliers, distributors, and health providers that rely on cross-border supply chains for imaging equipment and components. Tariff measures influence supplier decisions on where to source subassemblies, with many manufacturers reassessing global manufacturing footprints to mitigate added import costs and reduce exposure to policy volatility. In response, some producers have shifted component sourcing to alternative geographies or accelerated local assembly to avoid incremental duties and reduce lead-time risk.

Operationally, the cumulative impact of tariffs manifests through increased landed costs, lengthened procurement cycles, and the need for more sophisticated supply chain risk management. Procurement teams now place greater emphasis on total landed cost analysis, longer-term supplier contracts, and dual-sourcing strategies to preserve continuity of supply. Consequently, distributors and service providers reevaluate pricing structures and warranty terms to maintain margins while remaining competitive.

Clinicians and administrators experience these dynamics through delayed equipment deliveries and, in some cases, adjusted capital planning. In turn, health systems may prioritize existing fleet optimization, preventive maintenance, and extended service contracts over immediate replacement purchases. Importantly, regulatory compliance and customs documentation have gained prominence, requiring closer coordination among procurement, legal, and logistics teams. Looking forward, companies that proactively adapt their supply chain strategies, streamline customs procedures, and offer flexible commercial terms will minimize disruption and preserve access to essential diagnostic capabilities.

How modality-specific deployment across Diagnostic Centers and Hospitals shapes clinical workflows, procurement choices, and device design imperatives

Segmentation analysis reveals how modality and care setting intersect to shape clinical utility, purchasing rationale, and adoption patterns. Based on Central DXA, the landscape is organized around Diagnostic Centers and Hospitals, with Diagnostic Centers frequently deploying their systems to support Fracture Risk Assessment and Osteoporosis Assessment services that prioritize throughput and outpatient follow-up, while Hospitals leverage central DXA for inpatient and outpatient osteoporosis management as well as integrated fracture liaison programs that emphasize comprehensive care coordination. Based on Quantitative Ultrasound, the technology often finds a foothold in Diagnostic Centers that prioritize rapid screening for fracture risk and osteoporosis assessment within community screening initiatives, and in Hospitals where it complements central DXA for triage, perioperative evaluation, and bedside assessment when radiology access is constrained. Based on Peripheral DXA, the modality is typically deployed in Diagnostic Centers that seek mobile, lower-cost options for fracture risk and osteoporosis assessment during community outreach and primary care collaborations, and in Hospitals where peripheral devices support focused assessments, monitoring of targeted patient cohorts, and preoperative evaluations when central DXA access is limited.

These segmentation patterns carry meaningful implications for manufacturers and health system planners. Devices optimized for Diagnostic Centers must balance ease of use, compact footprints, and throughput-oriented software, while hospital-grade systems require integration capabilities, advanced reporting, and robust service-level agreements. Moreover, reimbursement policies and clinical pathways differ by setting, which affects procurement timelines and capital allocation. Therefore, aligning product design, sales strategy, and clinical training with the distinct operational realities of Diagnostic Centers and Hospitals will enhance adoption and clinical value realization.

Regional regulatory diversity, demographic trends, and care delivery models creating differentiated demand patterns and localized commercialization strategies across global markets

Regional dynamics influence clinical priorities, regulatory expectations, and commercial strategies in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, aging demographics and broad primary care networks have increased demand for accessible diagnostic pathways and integrated fracture prevention programs, prompting health systems to invest in both centralized and decentralized densitometry solutions that support longitudinal management and outcome tracking. Conversely, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, reimbursement models, and health infrastructure vary widely across countries; as a result, vendors often pursue region-specific regulatory clearances and flexible commercial models that accommodate public procurement cycles and national screening initiatives.

In the Asia-Pacific region, rapid urbanization, expanding private healthcare delivery, and a growing emphasis on preventive health services stimulate demand for portable technologies and cloud-enabled analytics that facilitate broad population screening and continuity of care across fragmented providers. Additionally, regional manufacturing capabilities and policy incentives in certain markets encourage local assembly and partnerships, which can reduce lead times and lower logistical barriers. Across regions, regulatory harmonization efforts, cross-border data governance, and varying reimbursement structures require tailored market-entry strategies. Consequently, companies that invest in regional regulatory expertise, adaptive commercial models, and localized support infrastructure will be better positioned to capture opportunities while managing operational risks.

Competitive advantage emerges from validated imaging performance, integrated analytics, robust service models, and partner-driven market access strategies

Competitive dynamics center on the interplay between device capability, software analytics, service provision, and commercial flexibility. Leading vendors differentiate through validated measurement precision, low-dose imaging, and interoperability with electronic health records and clinical decision support systems, while niche players emphasize portability, affordability, and targeted applications such as peripheral screening or community-based fracture risk initiatives. Service models also shape competition; companies offering bundled maintenance, remote diagnostics, and analytics-as-a-service demonstrate resilience in environments where capital budgets are constrained and health systems seek predictable operating expenditures.

Partnerships and channel strategies increasingly determine market access. Distributors that combine equipment sales with training programs, installation services, and local clinical education create stickiness with provider customers. Additionally, strategic alliances between device manufacturers and software developers accelerate the deployment of advanced risk assessment tools and population health management dashboards. From a product lifecycle perspective, vendors that maintain rigorous clinical validation, timely software updates, and clear post-market surveillance protocols preserve clinician trust and regulatory compliance. Ultimately, competitive advantage accrues to organizations that align technological innovation with reliable service delivery and adaptable commercial terms that meet the operational needs of diverse clinical settings.

Practical steps for vendors and providers to enhance clinical integration, build supply chain resilience, and expand service-driven commercial models for sustainable growth

Industry leaders should prioritize actions that strengthen clinical relevance, operational resilience, and commercial agility. First, invest in interoperability and clinical integration so that densitometry data flows seamlessly into electronic health records and treatment pathways; doing so increases clinical uptake and supports guideline-aligned decision-making. Second, diversify supply chains and consider regional assembly or dual sourcing to reduce exposure to trade disruptions and tariff volatility, thereby improving delivery predictability and cost control. Third, expand service offerings to include software-driven analytics, remote maintenance, and subscription pricing that convert capital expenditures into manageable operating expenses for health systems with constrained budgets.

Additionally, accelerate clinical validation studies that demonstrate device performance across diverse patient cohorts and imaging environments. Strengthen training and credentialing programs for operators to reduce variability and optimize diagnostic yield. Engage proactively with payers and policy makers to clarify reimbursement pathways and to highlight the value of early detection in reducing downstream fracture-related costs. Finally, pursue partnerships with healthcare systems, academic centers, and technology firms to co-develop population health tools and decision support modules that embed bone densitometry into broader chronic disease management strategies. Taken together, these steps will enhance adoption, mitigate risk, and create sustainable differentiation.

Transparent methodological approach combining expert interviews, regulatory review, and comparative product assessment to derive actionable and validated insights

This research synthesized primary and secondary evidence to produce actionable insights into technology deployment, clinical adoption, and commercial dynamics. Primary inputs included structured interviews with clinical leaders, procurement specialists, and industry executives, supplemented by product specifications, regulatory filings, and peer-reviewed literature that describe device performance and clinical utility. Secondary inputs comprised publicly available clinical guidelines, health system procurement documents, and manufacturer technical whitepapers that illuminate workflow integration and service models.

Analytical methods combined qualitative thematic analysis with comparative product assessment to identify performance differentiators, as well as scenario-based supply chain mapping to evaluate tariff and policy impacts on procurement timelines. Validation steps included expert review panels and cross-checking with regulatory documentation to ensure technical accuracy. Throughout, emphasis rested on transparency of assumptions and reproducibility of analyses. Limitations included variability in national reimbursement practices and heterogeneity in clinical pathways across institutions, which the study addressed by presenting adaptable strategic implications rather than prescriptive operational directives.

Synthesis of clinical trends, technology imperatives, and operational actions that together define the path to broader adoption and higher-value bone health diagnostics

In conclusion, bone densitometry is evolving from a niche diagnostic into a central component of preventive musculoskeletal care, driven by demographic change, technological innovation, and shifts in care delivery. The interplay between modality characteristics and care settings dictates how devices will be adopted and where clinical value will be realized. Concurrently, trade policy and supply chain considerations add operational complexity that requires proactive management by manufacturers and health systems alike.

Stakeholders who focus on interoperability, clinical validation, and flexible commercial arrangements will secure the greatest advantage. Moreover, regional nuances necessitate localized strategies for regulatory approval, distribution, and service support. By prioritizing robust analytics, operator training, and resilient sourcing, organizations can reduce risk and accelerate the translation of diagnostic capability into improved patient outcomes. Ultimately, the organizations that translate these insights into coordinated clinical, operational, and commercial actions will lead the transition to more accessible and effective bone health management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Densitometer Market, by Central DXA

  • 8.1. Diagnostic Centers
    • 8.1.1. Fracture Risk Assessment
    • 8.1.2. Osteoporosis Assessment
  • 8.2. Hospitals
    • 8.2.1. Fracture Risk Assessment
    • 8.2.2. Osteoporosis Assessment

9. Bone Densitometer Market, by Quantitative Ultrasound

  • 9.1. Diagnostic Centers
    • 9.1.1. Fracture Risk Assessment
    • 9.1.2. Osteoporosis Assessment
  • 9.2. Hospitals
    • 9.2.1. Fracture Risk Assessment
    • 9.2.2. Osteoporosis Assessment

10. Bone Densitometer Market, by Peripheral DXA

  • 10.1. Diagnostic Centers
    • 10.1.1. Fracture Risk Assessment
    • 10.1.2. Osteoporosis Assessment
  • 10.2. Hospitals
    • 10.2.1. Fracture Risk Assessment
    • 10.2.2. Osteoporosis Assessment

11. Bone Densitometer Market, by End User

  • 11.1. Hospitals
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Specialty Clinics
  • 11.4. Research Institutions

12. Bone Densitometer Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bone Densitometer Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bone Densitometer Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bone Densitometer Market

16. China Bone Densitometer Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. CompuMed, Inc.
  • 17.6. DMS Group, Inc.
  • 17.7. GE HealthCare Technologies Inc.
  • 17.8. Hitachi Aloka Medical, Ltd.
  • 17.9. Hologic, Inc.
  • 17.10. Medilink Co., Ltd.
  • 17.11. Medonica Co., Ltd.
  • 17.12. Mindways Software, Inc.
  • 17.13. Norland Medical Systems, Inc.
  • 17.14. OsteoSys Co., Ltd.
  • 17.15. Scanflex Healthcare AB
  • 17.16. Siemens Healthineers AG
  • 17.17. Sunlight Medical Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE DENSITOMETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BONE DENSITOMETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BONE DENSITOMETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE DENSITOMETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BONE DENSITOMETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE DENSITOMETER MARKET SIZE, BY FRACTURE RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BONE DENSITOMETER MARKET SIZE, BY OSTEOPOROSIS ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BONE DENSITOMETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE DENSITOMETER MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BONE DENSITOMETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BONE DENSITOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE DENSITOMETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 228. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL BONE DENSITOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BONE DENSITOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BONE DENSITOMETER MARKET SIZE, BY CENTRAL DXA, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA BONE DENSITOMETER MARKET SIZE, BY QUANTITATIVE ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BONE DENSITOMETER MARKET SIZE, BY PERIPHERAL DXA, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BONE DENSITOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BONE DENSITOMETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BONE DENSITOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)